Mesothelioma cancer is one such disease that can happen to anyone both you and me. But records state the major victims come from the worker class of the asbestos companies, shipping companies and construction yards including mines where asbestos is one of the major minerals dealt with. This is primarily a lung disorder that ultimately takes the shape of fatal cancer.
Caring a Mesothelioma patient is very tough. Caring here doesn't simply mean physical care. A Mesothelioma patient has to be given equal mental and emotional support to fight with the situation. Most of the time it has been observed that the patient completely loses faith in life.
Proper knowledge and guidance
Especially the near and dear ones of the patients must have adequate knowledge about the disease and also know what type of support should be given to the patient. There are doctors to look into the case but they are not available always. It is you who will be by the side of patient in his/her needs.
Treat the patient humbly and give him medicines and food at the right hour. The pain along the chest side is sometimes acute and unbearable. You must have an S.O.S. for instant relief. For Mesothelioma patients, morphine is a very good remedy. But a misconception prevails with the use of morphine and most of us refer it to be a sedative drug with other adverse side effects. Such preconceived notions have to be taken out of mind. Both the patient and the patient's relatives should have a positive mind setup and follow the doctor's prescription in an accurate manner. Otherwise you will welcome further troubles.
Well it is known to all of us that the Mesothelioma patient won't be able to sustain life with this cancer inside the body. But they too have every right to enjoy life till they close their eyes forever. Give them hope and happiness so that they live their life to the fullest even in this short time period. Let depression and despair not make shelter in their minds to blemish the rest of the days they are alive.
About the Author
Find more Mesothelioma and asbestos info online. For Credit repair related articles: http://www.credit-repair-fyi.info
Saturday, June 23, 2007
Friday, June 01, 2007
Beta Carotene and Vitamin A on Lung Cancer
Lung cancer and cardiovascular disease are major causes of death in the United States. It has been proposed that carotenoids and retinoids are agents that may prevent these disorders.
We conducted a multicenter, randomized, double-blind, placebo-controlled primary prevention trial — the Beta-Carotene and Retinol Efficacy Trial — involving a total of 18,314 smokers, former smokers, and workers exposed to asbestos. The effects of a combination of 30 mg of beta carotene per day and 25,000 IU of retinol (vitamin A) in the form of retinyl palmitate per day on the primary end point, the incidence of lung cancer, were compared with those of placebo.
A total of 388 new cases of lung cancer were diagnosed during the 73,135 person-years of follow-up (mean length of follow-up, 4.0 years). The active-treatment group had a relative risk of lung cancer of 1.28 (95 percent confidence interval, 1.04 to 1.57; P = 0.02), as compared with the placebo group. There were no statistically significant differences in the risks of other types of cancer. In the active-treatment group, the relative risk of death from any cause was 1.17 (95 percent confidence interval, 1.03 to 1.33); of death from lung cancer, 1.46 (95 percent confidence interval, 1.07 to 2.00); and of death from cardiovascular disease, 1.26 (95 percent confidence interval, 0.99 to 1.61). On the basis of these findings, the randomized trial was stopped 21 months earlier than planned; follow-up will continue for another 5 years.
After an average of four years of supplementation, the combination of beta carotene and vitamin A had no benefit and may have had an adverse effect on the incidence of lung cancer and on the risk of death from lung cancer, cardiovascular disease, and any cause in smokers and workers exposed to asbestos.
We conducted a multicenter, randomized, double-blind, placebo-controlled primary prevention trial — the Beta-Carotene and Retinol Efficacy Trial — involving a total of 18,314 smokers, former smokers, and workers exposed to asbestos. The effects of a combination of 30 mg of beta carotene per day and 25,000 IU of retinol (vitamin A) in the form of retinyl palmitate per day on the primary end point, the incidence of lung cancer, were compared with those of placebo.
A total of 388 new cases of lung cancer were diagnosed during the 73,135 person-years of follow-up (mean length of follow-up, 4.0 years). The active-treatment group had a relative risk of lung cancer of 1.28 (95 percent confidence interval, 1.04 to 1.57; P = 0.02), as compared with the placebo group. There were no statistically significant differences in the risks of other types of cancer. In the active-treatment group, the relative risk of death from any cause was 1.17 (95 percent confidence interval, 1.03 to 1.33); of death from lung cancer, 1.46 (95 percent confidence interval, 1.07 to 2.00); and of death from cardiovascular disease, 1.26 (95 percent confidence interval, 0.99 to 1.61). On the basis of these findings, the randomized trial was stopped 21 months earlier than planned; follow-up will continue for another 5 years.
After an average of four years of supplementation, the combination of beta carotene and vitamin A had no benefit and may have had an adverse effect on the incidence of lung cancer and on the risk of death from lung cancer, cardiovascular disease, and any cause in smokers and workers exposed to asbestos.
Subscribe to:
Posts (Atom)